Boehringer Ingelheim
David Woessner, PhD, MSCI, serves as Senior Associate Director and Team Lead for US Oncology Medical Science Liaisons at Boehringer Ingelheim, overseeing oncology pipeline development and cross-functional integration. Prior experience includes Director of US Project Management, focusing on strategic coordination for the oncology pipeline, and roles in medical science liaison functions, emphasizing relationships with oncology experts and clinical exchanges. David's academic background includes a PhD in Pharmacology and Toxicology and an MS in Clinical Investigation from the University of Utah, complemented by postdoctoral research at St. Jude Children's Research Hospital. David was also an active committee member for the American Association of Pharmaceutical Scientists, contributing to educational programs on biomarkers in translational medicine. Earlier roles included research positions at OHSU and the University of Montana, highlighting a robust foundation in biomedical research and project management.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
112 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.